Back to search

University of Thessaly (UTH)

Αναστολή της έκφρασης γονιδίων που ενέχονται στην οστεοαρθρίτιδα

Abstract

dc:description

Osteoarthritis (OA) is the most common disease of the joints, with higher incidence at ages over 60 years. It is a disease that affects all elements of the joint, with most prominent the articular cartilage. It can occur in all joints, with most frequent occurrence in the hand, foot, knee, spine and hip. It is considered a multi-factorial disease, in which genetic contribution has been found to play a significant role in its development and progression,.The developmental stages of the growth-plate differentiation of chondrocytes include proliferation, hypertrophy and finally cell death. The final product of growth-plate chondrocytes’, differentiation and maturation, is the resistant, permanent, adult articular cartilage. Under normal conditions, the chondrocytes in the permanent articular cartilage do not undergo proliferation, hypertrophic differentiation or apoptosis, in contrast with growth-plate chondrocytes. However, osteoarthritic chondrocytes adopt phenotypic characteristics of growth-plate chondrocytes and restart to proliferate and undergo hypertrophic differentiation, under the signal of various transcription and growth factors, enzymes, hormones and cytokines. Hypertrophy in OA is also linked with other phenotypic changes, as cartilage calcification, and has been is a correlation between cartilage calcification, clinical classification of the disease and the expression of collagen type X, a hypertrophy characteristic marker.The active metabolite of vitamin D is 1,25(ΟΗ)2D3, which plays an important role in chondrocytes’ hypertrophy. 1,25(ΟΗ)2D3 binds to its specific receptor VDR and participates in the regulation of genes’ expression, which are involved in hypertrophy and calcification in OA cartilage. Moreover, 1,25(ΟΗ)2D3, contributes to hypertrophic differentiation of chondrocytes, especially close to the calcified area of the cartilage, and in the formation of matrix vesicles in extracellular matrix, which contain Ca2+. Matrix vesicles are responsible for the formation of calcium containing crystals (CPPD, BCP), which erode the cartilage and are correlated with disease progression. Fibroblast growth factor 23 (FGF23) is a phosphaturic factor, which is also involved in the process of cartilage hypertrophy and calcification and promotes the premature differentiation of proliferating growth-plate chondrocytes to hypertrophic. FGF23 binds to specific receptors FGFRs and activates signaling pathways in the target cells. Particularly, FGF23 binding to FGFR1c promotes the activation of MAP-kinase pathway in chondrocytes. Moreover, FGF23 function involves the homeostasis of Ca2+/Pi metabolism and the regulation of 1,25(ΟΗ)2D3 metabolism through repression of 1α-hydroxylase activity. FGF23 has been found to be highly expressed in cells that calcify their extracellular matrix, like osteoblasts and chondrocytes and exhibits differentiated expression before and after calcification. Finally, increased extracellular levels of Pi exhibit important role in cartilage hypertrophy and calcification. Pi enters chondrocytes through Na+/Pi contrasporters, Pit-1, and promotes the expression of hypertrophy-related genes, as RUNX2, osteopontin and osteocalcin.Τhe objective of this study is the investigation of molecules which induce hypertrophy and calcification in osteoarthritic chondrocytes, like 1,25(ΟΗ)2D3 and Pi, the implicated molecular mechanisms and the investigation of the inhibition of their expression. We used articular cartilage samples from osteoarthritic patients, who were undergoing total knee replacement surgery and were not suffering from other rheumatic diseases, chondrodysplasias or autoimmune diseases. The control group was consisted from individuals who were hospitalized for injury or fracture repair. In the experimental part of the thesis were investigated:the role of 1,25(ΟΗ)2D3 through the expression of its receptor VDR in osteoarthritic and normal chondrocytes, the role of Pi through the expression of Na+/Pi cotransporters, Pit-1 και Pit-2 in osteoarthritic and normal chondrocytes, the role of the growth factor FGF23 and the transcription factor RUNX2 in osteoarthritic and normal chondrocytes, as well as their interaction,FGFR1c expression, a specific receptor for FGF23, and the signaling that is activated via FGF23 binding to FGFR1c in osteoarthritic and normal chondrocytes, 1,25(ΟΗ)2D3 or Pi implication in the activation of FGF23 signaling and their role in the induction of hypertrophy in normal chondrocytes,the impact of VDR or Pit-1, Pit-2 inhibition in the inversion of hypertrophic phenotype in OA chondrocytes, the additive effect of 1,25(ΟΗ)2D3 and Pi treatment in the induction of hypertrophy in normal chondrocytes.We observed up-regulated VDR and Pit-1, Pit-2 expression levels in OA chondrocytes compared to normal, suggesting that 1,25(ΟΗ)2D3, via the binding to its receptor VDR exhibits increased transcriptional activity in OA chondrocytes compared to normal. Moreover, we observed that Pi is accumulated in the extracellular matrix of OA chondrocytes and provokes the over-expression of Pit-1, Pit-2 cotransporters in order to enter the cells. We also observed that the phosphaturic growth factor FGF23 and the hypertrophy transcription factor RUNX2 are over-expressed in OA chondrocytes and furthermore FGF23 increases RUNX2 expression. Our data suggest that FGF23 and RUNX2 over-expression and interaction is associated with hypertrophy in OA chondrocytes contributing to disease progression. 1,25(ΟΗ)2D3 or Pi treatment in normal chondrocytes promoted FGF23 and FGFR1c expression and as a consequence activated MAPK pathway and ERK1/2 phosphorylation. The activation of MAPK signaling pathway resulted in the enhancement of hypertrophy-related genes’ expression, like RUNX2, COL10A1, osteopontin, osteocalcin, the induction of the catabolic metalloproteinase-13, and the apoptotic death of chondrocytes. Analysis of FGF23 promoter showed, for the first time, the presence of vitamin D response elements (VDREs), that permit the binding of 1,25(ΟΗ)2D3-VDR complex and the direct regulation of FGF23 transcription. Furthermore, we proceeded with VDR or Pit-1, Pit-2 inhibition in ΟΑ chondrocytes, which resulted in reduced FGF23 and FGFR1c expression, inactivation of MAPK pathway and reduced expression of all markers, as RUNX2, COL10A1, OPN, OC, MMP-13 and finally inhibition of apoptosis. The effect of VDR or Pit-1, Pit-2 inhibition confirms the observations from the 1,25(ΟΗ)2D3 or Pi treatment of normal chondrocytes, and furthermore reveals the mechanism that mediates the effects of 1,25(ΟΗ)2D3 and Pi in OA chondrocytes. The simultaneous inhibition of VDR and Pit-1, Pit-2, resulted in additive significant reduction of FGF23 and FGFR1c expression compared to the individual VDR or Pit-1, Pit-2 inhibition. Moreover, we observed the complete inactivation of MAPK pathway and significant reduced expression of all marker genes (COL10A1, OPN, OC, MMP-13) in ΟΑ chondrocytes.Our findings suggest the implication of 1,25(ΟΗ)2D3 and Pi in hypertrophy and calcification in OA chondrocytes. Specifically, 1,25(ΟΗ)2D3, via its binding to its receptor VDR, exhibited enhanced transcriptional activity in OA chondrocytes, which is further induced by the entry of elevated extracellular Pi levels. Subsequently, 1,25(ΟΗ)2D3 –VDR complex binds to VDREs, which are located in FGF23 promoter and promotes the enhancement of its expression. Then, FGF23 binds to FGFR1c and activates MAPK pathway, resulting in the expression of hypertrophy and ECM calcification related genes and finally to cartilage degeneration. Our results reveal new molecules, as 1,25(ΟΗ)2D3, which could be evaluated as a new therapeutic target.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Orfanidou, Timoklia
  • Ορφανίδου, Τιμόκλεια

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/33187

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Orfanidou, Timoklia; Ορφανίδου, Τιμόκλεια. Αναστολή της έκφρασης γονιδίων που ενέχονται στην οστεοαρθρίτιδα. University of Thessaly (UTH), 2012. http://hdl.handle.net/10442/hedi/33187